Skip to main content
. Author manuscript; available in PMC: 2010 Sep 1.
Published in final edited form as: Clin Cancer Res. 2009 Aug 18;15(17):5404–5413. doi: 10.1158/1078-0432.CCR-09-0365

Figure 3. Effect of RAD001 on the growth of cisplatin-sensitive CCC-derived tumor cells in vivo.

Figure 3

Athymic nude mice were inoculated s.c. with KOC7C cells or RMG1 cells. When the tumors reached an average size of about 50 mm3, mice were treated with placebo or 2.5 mg/kg RAD001 twice a week for 4 wks. A and C, appearance of subcutaneous tumors.B and D, graphs depicting weekly tumor volumes (mm3) for each treatment group. Points, mean; bars, SD. *, p< 0.05, significantly different from placebo-treated mice. **, p< 0.01, significantly different from placebo-treated mice.